Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Vaishali Pharma Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Vaishali Pharma Ltd: Earnings increased despite lower sales in the quarter ending Jun 2026. Sales fell 3.6% to ₹23 crore against Jun 2025. Net profit rose 16.4% to ₹1.49 crore against the same period a year earlier. Operating margin rose from 5.8% to 6.5% (0.7 percentage points higher). Borrowings were ₹19 crore in Mar 2026, 58.3% above the prior-year balance.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 9 October 2026, 9:49 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price7.92₹ per share
Reported P/E24.4Times
Book value per share5.29₹ per share
Reported ROCE8.93 %Reported return

Stored market and accounting figures

Price record: 9 October 2026, 9:49 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap103 Cr.
Current Price7.92
High / Low11.5/4.75
Stock P/E24.4
Book Value5.29
Dividend Yield0.00 %
ROCE8.93 %
ROE6.02 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings increased despite lower sales in the quarter ending Jun 2026. Sales fell 3.6% to ₹23 crore against Jun 2025. Net profit rose 16.4% to ₹1.49 crore against the same period a year earlier. Operating margin rose from 5.8% to 6.5% (0.7 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 13.4212.5727.9032.4018.0820.7927.9132.2523.7533.4524.6526.9322.89
Expenses 11.119.9224.9539.1915.7318.3726.5538.2922.3832.0623.0927.1321.40
Operating Profit 2.312.652.95-6.792.352.421.36-6.041.371.391.56-0.201.49
OPM % 17.21%21.08%10.57%-20.96%13.00%11.64%4.87%-18.73%5.77%4.16%6.33%-0.74%6.51%
Other Income 0.360.300.470.910.420.711.071.000.840.840.891.260.58
Interest 0.430.470.430.400.380.380.380.440.330.400.510.720.20
Depreciation 0.120.120.120.140.120.120.120.120.140.170.130.160.14
Profit before tax 2.122.362.87-6.422.272.631.93-5.601.741.661.810.181.73
Tax % 25.00%27.97%26.13%-26.95%25.11%25.10%24.87%-23.39%26.44%28.31%28.18%-50.00%13.87%
Net Profit 1.591.702.11-4.681.701.971.44-4.291.281.181.300.271.49
EPS in Rs 0.150.160.20-0.440.160.180.13-0.400.120.090.100.020.11

Last Updated: September 29, 2026, 4:51 pm

EARNINGS

Annual performance

Mar 2026

Earnings grew faster than sales in the year ending Mar 2026. Sales rose 10.1% to ₹109 crore against Mar 2025. Net profit rose 300.0% to ₹4.00 crore against the same period a year earlier. Operating margin rose from 1.0% to 3.7% (2.7 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:56 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 9567646875605476708699109108
Expenses 9566606573595169608598105104
Operating Profit -0133213792144
OPM % -0.3%0.8%5%4.1%2.8%1.5%4.9%9%13%1.9%0.6%3.8%3.9%
Other Income 4312222222344
Interest 3333333222222
Depreciation 0000000001011
Profit before tax 0-011101691155
Tax % -7%300%32%41%37%62%26%30%25%23%34%25%
Net Profit 0-011101471144
EPS in Rs 0.20-0.040.150.080.070.000.100.380.630.070.080.310.32
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%
Year-on-year profit growth table

YoY Net Profit Growth

Year2017-20182018-20192019-20202021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)0.00%0.00%-100.00%300.00%75.00%-85.71%0.00%300.00%
Change in YoY Net Profit Growth (%)0.00%0.00%-100.00%400.00%-225.00%-160.71%85.71%300.00%

Growth

Compounded Sales Growth
10 Years:0%
5 Years:11%
3 Years:9%
TTM:15%
Compounded Profit Growth
10 Years:18%
5 Years:94%
3 Years:-41%
TTM:-52%
Stock Price CAGR
10 Years:Not available
5 Years:24%
3 Years:8%
1 Year:-35%
Return on Equity
10 Years:7%
5 Years:8%
3 Years:6%
Last Year:2%

Last Updated: September 5, 2025, 1:50 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹19 crore in Mar 2026. They increased from ₹12 crore in Mar 2025 (58.3% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 4, 2026, 10:06 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 0.500.5037711111111112626
Reserves 331141511121630323943
Borrowings 252123181717182115131219
Other Liabilities 172518253028463424243335
Total Liabilities 46494564696686827980110123
Fixed Assets 211111112222
CWIP 000000001100
Investments 000000000005
Other Assets 44484362676484807677107116
Total Assets 46494564696686827980110123
CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹0.00 crore in Mar 2026. Reported free cash flow for the same period was ₹0.00 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 0.0% of the ₹4.00 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + -450-9432111-180
Cash from Investing Activity + 2311-0-0-0-101-0-5
Cash from Financing Activity + 2-8-18-4-3-20-2-1185
Net Cash Flow 00-000001-010-0
Free Cash Flow -550-10432011-18-0
CFO/OP 1,252%842%16%-326%212%433%78%31%28%185%-3,104%19%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-5.005.000.00-10.004.003.002.000.001.001.00-18.000.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 231 in Mar 2025. That is 62 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 116133221214240240286453282281209172
Inventory Days 261320711565420220
Days Payable 996614510013613016932116312095116
Cash Conversion Cycle 43809612111511512313712218111677
Working Capital Days 599825149798124146111208169231
ROCE %19%14%13%16%13%10%7%10%19%22%6%5%
SHAREHOLDERS

Ownership trends

Jul 2026

Promoters held 30.54% in Jul 2026. Their share was 1.07 percentage points lower than in Jun 2026. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
Promoters 26.62%26.32%26.32%26.32%26.32%26.32%26.32%26.32%31.61%31.61%31.61%30.54%
Public 73.38%73.68%73.68%73.67%73.68%73.68%73.68%73.68%68.39%68.39%68.39%69.46%
No. of Shareholders 9,1819,3909,47918,98327,54628,87428,68227,75227,14826,53426,67126,697

This stock is not held by any mutual fund.

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.060.686.263.820.99
Diluted EPS (Rs.) 0.060.645.913.820.99
Cash EPS (Rs.) 0.091.146.744.251.40
Book Value[Excl.RevalReserv]/Share (Rs.) 4.9833.4131.2624.9921.26
Book Value[Incl.RevalReserv]/Share (Rs.) 4.9833.4131.2624.9921.26
Revenue From Operations / Share (Rs.) 7.5980.4966.0571.8950.99
PBDIT / Share (Rs.) 0.252.9610.778.204.21
PBIT / Share (Rs.) 0.212.4810.297.763.81
PBT / Share (Rs.) 0.090.868.395.431.33
Net Profit / Share (Rs.) 0.060.676.263.810.99
PBDIT Margin (%) 3.323.6716.3011.398.26
PBIT Margin (%) 2.833.0815.5810.797.46
PBT Margin (%) 1.231.0712.697.552.61
Net Profit Margin (%) 0.820.839.475.301.94
Return on Networth / Equity (%) 1.252.0020.0215.264.66
Return on Capital Employeed (%) 4.025.6823.1727.5714.94
Return On Assets (%) 0.740.898.364.921.21
Long Term Debt / Equity (X) 0.060.100.150.110.18
Total Debt / Equity (X) 0.170.350.410.780.71
Asset Turnover Ratio (%) 1.041.090.860.900.70
Current Ratio (X) 2.612.252.271.471.37
Quick Ratio (X) 2.492.242.171.461.36
Inventory Turnover Ratio (X) 38.160.000.000.000.00
Interest Coverage Ratio (X) 2.081.835.663.521.70
Interest Coverage Ratio (Post Tax) (X) 1.521.414.292.641.40
Enterprise Value (Cr.) 173.94161.15166.5589.1749.85
EV / Net Operating Revenue (X) 1.761.872.391.180.92
EV / EBITDA (X) 52.7850.8214.6610.3211.22
MarketCap / Net Operating Revenue (X) 1.661.742.210.920.63
Price / BV (X) 2.534.194.672.651.53
Price / Net Operating Revenue (X) 1.661.742.210.920.63
EarningsYield 0.000.000.040.050.03

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Vaishali Pharma Ltd 103 Cr. 7.92 11.5/4.7524.4 5.290.00 %8.93 %6.02 % 2.00
Pharmaids Pharmaceuticals Ltd 109 Cr. 30.8 53.9/25.6 13.50.00 %18.5 %26.5 % 10.0
Concord Drugs Ltd 93.5 Cr. 71.0 92.5/61.045.8 36.80.00 %5.19 %2.52 % 10.0
Denis Chem Lab Ltd 90.7 Cr. 65.4 94.6/56.111.4 66.03.83 %14.0 %9.52 % 10.0
Ind-Swift Ltd 85.4 Cr. 15.8 /10.9 74.20.00 %11.9 %Not available 2.00
Industry Average17,115.08 Cr1,214.7453.42211.240.40%26.16%16.59%6.06

All Competitor Stocks of Vaishali Pharma Ltd

Explore Industry-wise Company financial data